The Sato Lab (Kei Sato)'s Avatar

The Sato Lab (Kei Sato)

@systemsvirology.bsky.social

Professor, Division of Systems Virology, The Institute of Medical Science, The University of Tokyo Founder, The Genotype to Phenotype Japan (G2P-Japan) Consortium Representative Director, G2P-Japan Association Lab website: https://x.gd/1Z1lW

571 Followers  |  103 Following  |  40 Posts  |  Joined: 30.11.2024  |  2.0527

Latest posts by systemsvirology.bsky.social on Bluesky

Should be amazing๐Ÿคฉ Thanks Karim for leading this. See you so soon in Montpellier๐Ÿ˜š

17.09.2025 12:48 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Frontiers | The spike S2 substitution, P804L, drives the adaptation of BANAL-20โ€“236 to a broad range of Rhinolophus bat ACE2 Understanding how bat coronaviruses circulate in wildlife, including bats in nature, can help assess the risks of cross-species transmission of potentially p...

Our new study is out at Frontiers in Virology! We conducted passaging experiments and demonstrated that the spike S2 substitution, P804L, drives the adaptation of BANAL-20โ€“236 to a broad range of Rhinolophus bat ACE2. Congrats Bill๐ŸŽŠ!
www.frontiersin.org/journals/vir...

16.09.2025 23:18 โ€” ๐Ÿ‘ 5    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image Post image Post image

Great reunion of COVID gangsters in my lab!! Welcome back, Ralph๐Ÿ‡บ๐Ÿ‡ธ and Angie๐Ÿ‡จ๐Ÿ‡ฆ๐Ÿ˜Ž

Also thanks for coming, Yvonne๐Ÿ‡ธ๐Ÿ‡ฌ, Peter๐Ÿ‡ธ๐Ÿ‡ฌ and Daniel๐Ÿ‡ฆ๐Ÿ‡บ๐Ÿท๐Ÿฆ‡โ€ผ๏ธ

05.09.2025 14:42 โ€” ๐Ÿ‘ 7    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Virological characteristics of the SARS-CoV-2 NB.1.8.1 variant After the spread of SARS-CoV-2 JN.1, its subvariants, such as KP.3 (JN.1.11.1.3)1 and KP.3.1.1 (JN.1.11.1.3.1.1),2 and XEC (a recombinant lineage of two JN.1 subvariants),3 emerged and rapidly spread ...

BREAKING๐Ÿ”” The 53th paper from G2P-Japan๐Ÿ‡ฏ๐Ÿ‡ต is out at Lancet Infectious Diseases @thelancetinfdis.bsky.social. We elucidated the virological characteristics of SARS-CoV-2 NB.1.8.1. Please repost๐Ÿ”ฅ
www.thelancet.com/journals/lan...

07.06.2025 02:04 โ€” ๐Ÿ‘ 67    ๐Ÿ” 29    ๐Ÿ’ฌ 4    ๐Ÿ“Œ 3
Post image

The end of US leadership in science, technology, and innovation.

All in one little table.

A tremendous gift to China, courtesy of the GOP.

nsf-gov-resources.nsf.gov/files/00-NSF...

30.05.2025 21:26 โ€” ๐Ÿ‘ 1054    ๐Ÿ” 421    ๐Ÿ’ฌ 37    ๐Ÿ“Œ 29
Preview
Univ. of Tokyo mulls accepting Harvard foreign students if barred The University of Tokyo. (Mainichi) TOKYO (Kyodo) -- The University of Tokyo said Monday it is considering temporarily accepting international students from Harvard University if they are affected ...

PLEASE REPOST๐Ÿ”ˆ
If The University of Tokyo officially accepts the students from Harvard University, our lab would be happy to consider this opportunity๐Ÿ’ช๐Ÿป Work together with us๐Ÿ”ฅ Please send DM if you have any interests๐Ÿ“ฉ
www.alojapan.com/1283049/univ...

26.05.2025 11:39 โ€” ๐Ÿ‘ 40    ๐Ÿ” 16    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1
Post image

We demonstrated that SARS-CoV-2 JN.1 recombinant protein vaccine induces the neutralizing antibodies effective not only against JN.1 but also against a variety of variants including XEC. 2/2

17.04.2025 03:59 โ€” ๐Ÿ‘ 42    ๐Ÿ” 13    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1
Preview
Antiviral humoral immunity against SARS-CoV-2 omicron JN.1 subvariants induced by JN.1 recombinant protein vaccine

BREAKING๐Ÿ”” The 51st paper from G2P-Japan๐Ÿ‡ฏ๐Ÿ‡ต is out at Vaccine. We evaluated the antiviral activity of neutralizing antibodies induced by SARS-CoV-2 JN.1 recombinant protein vaccine against SARS-CoV-2. Please repost๐Ÿ”ฅ 1/
www.sciencedirect.com/science/arti...

17.04.2025 03:59 โ€” ๐Ÿ‘ 41    ๐Ÿ” 24    ๐Ÿ’ฌ 4    ๐Ÿ“Œ 1

Compared to 2024: 33โ†’36
23๐Ÿ‡ฏ๐Ÿ‡ต + 13๐ŸŒ: 5๐Ÿ‡จ๐Ÿ‡ณ 3๐Ÿ‡น๐Ÿ‡ญ 1๐Ÿ‡ต๐Ÿ‡ญ 1๐Ÿ‡ฌ๐Ÿ‡ท 1๐Ÿ‡ฎ๐Ÿ‡ฉ 1๐Ÿ‡ฐ๐Ÿ‡ท 1๐Ÿ‡จ๐Ÿ‡ญ
18โ™‚ + 18โ™€ = 50% male!!

cf. 2024:
21๐Ÿ‡ฏ๐Ÿ‡ต 4๐Ÿ‡จ๐Ÿ‡ณ 2๐Ÿ‡ต๐Ÿ‡ญ 2๐Ÿ‡น๐Ÿ‡ญ 1๐Ÿ‡บ๐Ÿ‡ธ 1๐Ÿ‡ฌ๐Ÿ‡ท 1๐Ÿ‡ฎ๐Ÿ‡ฉ 1๐Ÿ‡ฆ๐Ÿ‡บ

14.04.2025 08:19 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

Here is the Sato Lab, 2025๐Ÿ˜Ž!
๐Ÿ‡จ๐Ÿ‡ณ๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡จ๐Ÿ‡ณ๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฐ๐Ÿ‡ท๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡จ๐Ÿ‡ณ๐Ÿ‡ฌ๐Ÿ‡ท๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡น๐Ÿ‡ญ๐Ÿ‡จ๐Ÿ‡ญ๐Ÿ‡น๐Ÿ‡ญ๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡น๐Ÿ‡ญ๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ต๐Ÿ‡ญ๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡ฎ๐Ÿ‡ฉ๐Ÿ‡ฏ๐Ÿ‡ต๐Ÿ‡จ๐Ÿ‡ณ๐Ÿ‡จ๐Ÿ‡ณ

14.04.2025 08:18 โ€” ๐Ÿ‘ 14    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Beyond MERS: Merbecovirus receptor plasticity calls for emergence preparedness Three studies recently published in Cell reveal distinct ACE2 binding interactions across the merbecoviruses, uncovering how HKU5 can use ACE2s of many non-human hosts and identifying a novel HKU5 lin...

A new preview article is out at Cell Host & Microbe @cp-cellhostmicrobe.bsky.social! We summarized the 3 Cell papers focused on the characteristics of HKU5, a #merbecovirus. Great job Jarel @jarelelgin.bsky.social, Spyros @spyroslytras.bsky.social , and Jumpei!!

www.cell.com/cell-host-mi...

10.04.2025 01:17 โ€” ๐Ÿ‘ 20    ๐Ÿ” 10    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

A new preprint is out at @biorxivpreprint! Here we demonstrated that some pangolin coronaviruses are more sensitive to SARS-CoV-2 vaccine sera than SARS-CoV-2 itself, and interestingly, this was determined by only one amino acid residue positioned at 519 in spike๐Ÿฆ 
www.biorxiv.org/content/10.1...

03.04.2025 15:13 โ€” ๐Ÿ‘ 20    ๐Ÿ” 12    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 2

All of which are American dreams๐Ÿ‡บ๐Ÿ‡ธ

31.03.2025 12:54 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Sadly this person seems to be a virologist as well

29.03.2025 19:51 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0

What a shame. I am just taking about the possibility for scientific collaboration with US scientists. Why the conspiracy theory people in X simplistically talk about โ€œGOFโ€ experiments? I have never talked about such topics before.

29.03.2025 13:29 โ€” ๐Ÿ‘ 18    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Thanks Angie for your flattering๐Ÿ˜

Yes letโ€™s make it better together๐Ÿ’ช๐Ÿป

29.03.2025 05:12 โ€” ๐Ÿ‘ 11    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Thanks Niema for kind words.
I just hope/wish it would get better, and it would be great if I can do something for it.

Let us do it together๐Ÿ’ช๐Ÿป Science saves the world!!

29.03.2025 04:31 โ€” ๐Ÿ‘ 4    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

For US๐Ÿ‡บ๐Ÿ‡ธ scientists/virologists๐Ÿฆ  - if you want to find better ways for your science and career, please let me know. Let us find better ways. Please do repost/retweet

29.03.2025 01:24 โ€” ๐Ÿ‘ 55    ๐Ÿ” 35    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 5

Thanks for your kind introduction๐Ÿ˜
But what does โ€˜anotherโ€™ mean๐Ÿค”??

25.03.2025 14:54 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Molecular basis of sarbecovirus evolution and receptor tropism in natural hosts, potential intermediate hosts, and humans The spike protein of many sarbecoviruses binds to the angiotensin-converting enzyme 2 (ACE2) receptor and facilitates viral entry. The diversification of the sarbecovirus spike gene and the mammalian ACE2 gene suggests that sarbecoviruses and their hosts have co-evolved, and the genetic diversity in these genes affects the host tropism of sarbecoviruses. Better comprehending the evolutionary potential of sarbecoviruses can lead to preparedness for the next pandemic. However, the host tropism of sarbecoviruses is not fully understood. Here, we performed round-robin pseudovirus infection assays using 53 sarbecoviruses and ACE2s from 17 mammals to elucidate the ACE2 tropism of sarbecoviruses in natural hosts, potential intermediate hosts and humans. We determined the factors responsible for the ACE2 tropism of sarbecoviruses through structural, phylogenetic analyses, and infection experiments, revealing which substitutions can expand the host range of sarbecoviruses. These results highlight the mechanisms modulating host tropism throughout sarbecovirus evolution. ### Competing Interest Statement Spyros Lytras has received consulting fees from EcoHealth Alliance. Jumpei Ito has consulting fees from Moderna Japan Co., Ltd. Kei Sato has consulting fees from Moderna Japan Co., Ltd. and Takeda Pharmaceutical Co. Ltd., and honoraria for lectures from Moderna Japan Co., Ltd. and Shionogi & Co., Ltd. The other authors declare no competing interests. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

A new preprint is out at biorxiv!

Here we performed round-robin pseudovirus experiments using 53 sarbecoviruses๐Ÿฆ  and ACE2s from 17 mammals to elucidate the ACE2 tropism of sarbecoviruses in natural hosts๐Ÿฆ‡, potential intermediate hosts๐Ÿฆซ and humans๐Ÿ‘ค

www.biorxiv.org/content/10.1...

25.03.2025 08:09 โ€” ๐Ÿ‘ 32    ๐Ÿ” 12    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 2

Here's the latest variant picture with a global scope.

The big news this week was the emergence of BA.3.2, a saltation evolving for around 3 years in a chronic case and now transmitting in South Africa.

Hereโ€™s my thread on BA.3.2:
bsky.app/profile/mike...
๐Ÿงต

15.03.2025 10:27 โ€” ๐Ÿ‘ 31    ๐Ÿ” 9    ๐Ÿ’ฌ 3    ๐Ÿ“Œ 2

๐Ÿ’ช๐Ÿป

13.03.2025 14:02 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Appreciated Eddie. Will keep doing it๐Ÿ’ช๐Ÿป!!

13.03.2025 03:59 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Four ways COVID changed virology: lessons from the most sequenced virus of all time After 150,000 articles and 17 million genome sequences, what has science taught us about SARS-CoV-2?

So honored to be introduced in a news feature article in Nature @nature.com with a series of COVID gangsters๐Ÿ˜Ž!!
www.nature.com/articles/d41...

13.03.2025 02:12 โ€” ๐Ÿ‘ 30    ๐Ÿ” 11    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0
Preview
Virological characteristics of the SARS-CoV-2 LP.8.1 variant After the rapid spread of the SARS-CoV-2 JN.1 (BA.2.86.1.1) variant,1 several descendant lineages of JN.1, including KP.2 (JN.1.11.1.2),2 KP.3 (JN.1.11.1.3),2 and KP.3.1.1 (JN.1.11.1.3.1.1),3 have eme...

BREAKING๐Ÿ”” The 50th๐ŸŽ‰ paper from G2P-Japan๐Ÿ‡ฏ๐Ÿ‡ต is out at Lancet Infectious Diseases
@TheLancetInfDis. We elucidated the virological characteristics of SARS-CoV-2 LP.8.1. Please repost๐Ÿ”ฅ
www.thelancet.com/journals/lan...

12.02.2025 02:39 โ€” ๐Ÿ‘ 38    ๐Ÿ” 23    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 3

๐Ÿคฉ

31.01.2025 05:44 โ€” ๐Ÿ‘ 5    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Huge thanks for your participation in #CSHApandemic! I hope you enjoyed the time in the conference in Awaji island as well as your visit in my lab๐Ÿ˜

04.01.2025 12:05 โ€” ๐Ÿ‘ 7    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
COVID 5 years later: Learning from a pandemic many are forgetting Five years after SARS-CoV-2 surfaced, scientists reflect and look ahead to the next threat

Five years after #SARSCoV2 surfaced, scientists reflect and look ahead to the next threat. scim.ag/4j4CZsn

03.01.2025 16:23 โ€” ๐Ÿ‘ 62    ๐Ÿ” 20    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 2
Preview
COVID 5 years later: Learning from a pandemic many are forgetting Five years after SARS-CoV-2 surfaced, scientists reflect and look ahead to the next threat

COVID 5 years later: Learning from a pandemic many are forgetting @science.org written by @cohenjon.bsky.social

www.science.org/content/arti...

02.01.2025 19:27 โ€” ๐Ÿ‘ 12    ๐Ÿ” 7    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
How We Can Stop the Next Viral Pandemic A new combo of climate and habitat crises, along with immune system stress, is driving more bat-borne viruses to afflict us

The Next Viral Pandemic Is Coming. Hereโ€™s How We Can Stop It
www.scientificamerican.com/article/the-...

02.01.2025 00:58 โ€” ๐Ÿ‘ 17    ๐Ÿ” 7    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 2

@systemsvirology is following 20 prominent accounts